M&A Deal Summary

Charles River Laboratories International Acquires Galapagos NV - CRO Services Division

On March 13, 2014, Charles River Laboratories International acquired life science company Galapagos NV - CRO Services Division from Galapagos for 129M EUR

Acquisition Highlights
  • This is Charles River Laboratories International’s 8th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 9th largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 1st transaction in Belgium.

M&A Deal Summary
Date 2014-03-13
Target Galapagos NV - CRO Services Division
Sector Life Science
Buyer(s) Charles River Laboratories International
Sellers(s) Galapagos
Deal Type Divestiture
Deal Value 129M EUR

Target

Galapagos NV - CRO Services Division

Mechelen, Belgium
The CRO services division of Galapagos NV, which includes both Argenta and BioFocus are global leaders in integrated drug discovery services, with a predominant focus on in vitro capabilities.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

website

Category Company
Founded 1947
Sector Life Science
Employees18,600
Revenue 3.5B USD (2021)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.

DEAL STATS #
Overall 9 of 31
Sector (Life Science) 8 of 28
Type (Divestiture) 2 of 4
Country (Belgium) 1 of 1
Year (2014) 1 of 5
Size (of disclosed) 9 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 Vital River Laboratories

Beijing, China

Vital River Laboratories Co. Ltd. is a provider of research models and related services in China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-31 Argenta Discovery 2009

Harlow, United Kingdom

Argenta Discovery 2009 Ltd. is a drug discovery company.

Buy -

Seller(S) 1

SELLER

Galapagos

Mechelen, Belgium

website

Category Company
Founded 1999
Sector Life Science
Employees1,397
Revenue 478M EUR (2020)
DESCRIPTION

Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.

DEAL STATS #
Overall 1 of 4
Sector (Life Science) 1 of 4
Type (Divestiture) 1 of 4
Country (Belgium) 1 of 1
Year (2014) 1 of 3
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-01 Compound Focus

385 Oyster Point Boulevard Suite 1, California, United States

Compound Focus, Inc. is a small molecule compound management services.

Buy €13M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-31 Argenta Discovery 2009

Harlow, United Kingdom

Argenta Discovery 2009 Ltd. is a drug discovery company.

Sell -
Mergr

Product

Company

Legal